Clinical trial
Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram…
NCT00035425 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00035425 |
|---|---|
| Title | Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection |
| Official title | A Randomized, Double-Blind Trial Comparing Linezolid To Vancomycin In The Empiric Treatment Of Febrile Neutropenic Oncology Patients With Suspected Gram-Positive Infections |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Febrile Neutropenia |
| Intervention type | Drug |
| Interventions | linezolid, vancomycin |
| Enrollment | 120 |
| Start date | Nov 1, 2001 |
| Completion | Nov 1, 2002 |
| First posted | May 6, 2002 |
| Last update posted | Dec 1, 2009 |
| Countries | Argentina, Brazil, Chile, Colombia, Finland, Mexico, Pakistan, Peru, United States, Venezuela |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: